News Focus
News Focus
Followers 84
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: Protector post# 280096

Friday, 12/02/2016 7:21:20 AM

Friday, December 02, 2016 7:21:20 AM

Post# of 347009
I can understand the wooden chair and all want to keep their comfy cushion chairs till the time is right for Peregrine.... but I wonder what type of chair Rahul ex-Peregrine analyst sits on these days? : ) I was hoping some others would start speaking out and aim for a BOD position somewhere...

That entire thing still has me thinking and wondering that if Rahul knew so much there still must be some more trying to position themselves but I hope Peregrine wants to surprise us a bit sooner than later

"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline."
-- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y